Drugs / Afluria Quad
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05734040 | May → Aug 2023 | influenza | Osivax | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Afluria Quad | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05734040 ↗ |
| Modality | Vaccine | “Inactivated and purified split influenza vaccine” NCT05734040 ↗ |
| Route | Intramuscular | “One single administration intramuscularly on Day 1” NCT05734040 ↗ |